September 23, 2017August 24, 2022 VIMPAT Receives EU Approval for Expanded Pediatric Use News The European Commission has approved the expansion of the use of UCB’s VIMPAT (lacosamide) to include monotherapy and adjunctive therapy of partial-onset (focal) seizures ... Read more